XT
AMPE

XTX Topco’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

XTX Topco’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-359
Closed -$61K – 1051
2021
Q4 		$61K Buy
359
+309
+618% +$115K 0.03% 543
2021
Q3 		$25K Buy
+50
New +$23.2K 0.01% 635

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

XTX Topco's AMPE Position: Q1 2022 in Review

XTX Topco sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022, closing a stake of 359 shares — an estimated $61K sold.

XTX Topco first reported a position in AMPE in Q3 2021 and held it in 2 quarters. The position peaked at $61K in Q4 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • XTX Topco reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2022 after selling out during the quarter.
  • XTX Topco sold 359 Ampio Pharmaceuticals Inc. shares in Q1 2022, an estimated $61K.
  • XTX Topco first reported a position in Ampio Pharmaceuticals Inc. in Q3 2021 and held it in 2 quarters.
  • XTX Topco's Ampio Pharmaceuticals Inc. position peaked at $61K in Q4 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on XTX Topco's 13F filing for Q1 2022, filed 13 May 2022.